Skip to main content

Booth Bruce's Form 4 filing

Sionna Therapeutics, Inc. (SION) · filed Feb 10, 2025

Accession no.
0000950170-25-017029
Filed
Feb 10, 2025
Trade date
Feb 10, 2025
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 5 derivative transactions. Open-market purchases total $1.08M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Booth BruceCIK 0001451612Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 10, 2025Common StockCConversionAcquired+2,886,293––2,886,293Indirect
Feb 10, 2025Common StockCConversionAcquired+747,727––747,727Indirect
Feb 10, 2025Common StockPPurchaseAcquired+60,000$18.00+$1,080,000807,727Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 10, 2025Common StockCConversionDisposed−719,355$0.00$00Indirect
Feb 10, 2025Common StockCConversionDisposed−1,236,271$0.00$00Indirect
Feb 10, 2025Common StockCConversionDisposed−888,599$0.00$00Indirect
Feb 10, 2025Common StockCConversionDisposed−42,068$0.00$00Indirect
Feb 10, 2025Common StockCConversionDisposed−747,727$0.00$00Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)